Volume 55, Issue 3, Pages (March 1999)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Volume 54, Issue 2, Pages (August 1998)
Volume 69, Issue 5, Pages (March 2006)
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery  Wolfgang C. Winkelmayer, Robert J. Glynn,
Volume 65, Issue 5, Pages (May 2004)
Volume 82, Issue 5, Pages (September 2012)
Volume 66, Issue 1, Pages (July 2004)
The Methylenetetrahydrofolate Reductase 677C→T Polymorphism as a Modulator of a B Vitamin Network with Major Effects on Homocysteine Metabolism  Steinar.
Prehypertension and chronic kidney disease: the ox or the plow?
G protein β3 subunit C825T polymorphism in primary IgA nephropathy
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 66, Issue 1, Pages (July 2004)
Volume 77, Issue 8, Pages (April 2010)
Kamyar Kalantar-Zadeh  Kidney International 
Peripheral microvascular parameters in the nephrotic syndrome
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 77, Issue 1, Pages 5-6 (January 2010)
How to interpret the eGFR in patients with small body surface area
Targets to retard the progression of diabetic nephropathy
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Volume 61, Issue 3, Pages (March 2002)
Volume 71, Issue 5, Pages (March 2007)
Renal vascular sclerosis is associated with inherited thrombophilias
Volume 71, Issue 11, Pages (June 2007)
Gentamicin pharmacokinetics during slow daily home hemodialysis
Volume 77, Pages S8-S11 (March 2010)
U-shaped effect of eGFR and mortality
Volume 65, Issue 2, Pages (February 2004)
Volume 70, Issue 12, Pages (December 2006)
Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease  Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.
Volume 70, Issue 1, Pages (July 2006)
Should kidney donors be genotyped for APOL1 risk alleles?
Volume 85, Issue 3, Pages (March 2014)
Volume 55, Issue 6, Pages (June 1999)
Impact of gender on the renal response to angiotensin II
Drug Dose Adjustments in Patients With Renal Impairment
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Volume 73, Issue 5, Pages (March 2008)
Methods for guideline development
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
Genetic determinants of the homocysteine level
Volume 85, Issue 1, Pages 3-4 (January 2014)
Volume 58, Issue 2, Pages (August 2000)
Volume 66, Issue 3, Pages (September 2004)
Volume 80, Issue 3, Pages (August 2011)
Volume 87, Issue 5, Pages (May 2015)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 61, Issue 5, Pages (May 2002)
A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE  L.F. Quintana, B. Guzmán, S. Collado,
Long-term survival in renal transplant recipients with graft function
Volume 74, Issue 9, Pages (November 2008)
Volume 79, Issue 4, Pages (February 2011)
Volume 60, Issue 1, Pages (July 2001)
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
The Danish Renal Biopsy Register
Volume 66, Issue 1, Pages (July 2004)
Volume 65, Issue 2, Pages (February 2004)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Volume 69, Issue 10, Pages (May 2006)
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.
Volume 55, Issue 3, Pages (March 1999)
Volume 61, Issue 1, Pages (January 2002)
Volume 70, Issue 10, Pages (November 2006)
Friends, social networks, and progressive chronic kidney disease
Volume 67, Issue 2, Pages (February 2005)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Presentation transcript:

Volume 55, Issue 3, Pages 1072-1080 (March 1999) Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients  Manuela Födinger, Gabriele Wölfl, Gottfried Fischer, Susanne Rasoul-Rockenschaub, Rainer Schmid, Walter H. Hörl, Gere Sunder- Plassmann  Kidney International  Volume 55, Issue 3, Pages 1072-1080 (March 1999) DOI: 10.1046/j.1523-1755.1999.0550031072.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Nonadjusted mean total homocysteine (□; μmol/liter) and folate (▪; nmol/liter) plasma concentrations in kidney graft recipients matched for sex, age, glomerular filtration rate (GFR), and body mass index with respect to the C677T MTHFR gene polymorphism (63 patients in each genotype group). Whiskers denote ±SD. *P < 0.05 for plasma folate levels of the wild-type (CC) vs. heterozygous (CT) and homozygous mutant (TT) genotype patients; **P < 0.05 for total homocysteine concentrations of TT vs. CT and CC patients. Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Nonadjusted total homocysteine (tHcy) plasma concentrations according to the glomerular filtration rate (GFR) in the three groups of kidney graft recipients with (A) wild-type (CC), (B) heterozygous (CT), and (C) homozygous mutant (TT) MTHFR alleles. Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Mean total homocysteine (tHcy) concentrations in patients with a glomerular filtration rate (GFR)> the whole sample median (▪) and in patients with GFR ≤ the sample median (□) according to the MTHFR C677T gene polymorphism (63 patients in each genotype group). *P < 0.05 for plasma total homocysteine concentrations of TT vs. CT and CC patients with GFR ≤ sample median; **P < 0.05 for plasma total homocysteine concentrations of TT vs. CT and CC patients with a GFR more than sample median. Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 1072-1080DOI: (10. 1046/j. 1523-1755 Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 1072-1080DOI: (10. 1046/j. 1523-1755 Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 1072-1080DOI: (10. 1046/j. 1523-1755 Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 1072-1080DOI: (10. 1046/j. 1523-1755 Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 1072-1080DOI: (10. 1046/j. 1523-1755 Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 1072-1080DOI: (10. 1046/j. 1523-1755 Kidney International 1999 55, 1072-1080DOI: (10.1046/j.1523-1755.1999.0550031072.x) Copyright © 1999 International Society of Nephrology Terms and Conditions